Lü Su

Research areas : imaging of cerebrovascular diseases and brain tumors; artificial intelligence in medical imaging; psychiatric imaging and its clinical translation; neuropsychiatric radiological diagnosis.

Cutting-edge technologies: brain perfusion, functional magnetic resonance imaging of the brain, brain tumor radiomics, AI brain lesion identification; the world's first "Psychoradiology"; leading the development of the first Chinese guidelines for the standardized application of MR brain structural imaging technology in schizophrenia; the world's first psychiatric imaging clinic; hyperpolarized 13C magnetic resonance metabolic imaging.

Areas of expertise: Imaging-assisted diagnosis and efficacy prediction of mental illnesses such as schizophrenia, depression, and bipolar disorder; imaging diagnosis of neurological diseases.

Academic Highlights: Recipient of the National Natural Science Foundation of China (2013) Excellent Young Scientists Fund, National High-Level Talent (Ministry of Education), Member of the Neurology Group of the Radiology Branch of the Chinese Medical Association; recipient of four provincial and ministerial first-class awards, including the Second Prize of the National Natural Science Award and the First Prize of the Sichuan Provincial Science and Technology Progress Award; Fraunhofer-Bessel Research Award (the most important international award from the Humboldt Foundation of Germany), Shulan Youth Medical Award; presided over multiple National Natural Science Foundation of China projects, with in-depth research on complex central nervous system lesions, and leading domestic research in AI translational studies of brain tumors and stroke imaging. Published 146 SCI papers (64 first/corresponding author papers) in journals such as Nature Mental Health, American Journal of Psychiatry, JAMA Psychiatry, Radiology, and PNAS, with an H-index of 41; research findings have been included in 14 international consensus statements, handbooks, and guidelines.